An interventional study of Early laparoscopic cholecystectomy and Delayed Laparoscopic cholecystectomy in Cholelithiasis Associated With Common Bile Duct Stones, sponsored by Rija Zainab. Completed at 1 site in Pakistan. Open to participants aged 14 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Rija Zainab · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Cholelithiasis with a site in Pakistan — 2 open to participants now, 2 under way, none of them phase 3. Cholelithiasis · Pakistan.
Among the 12 studies in Cholelithiasis with a site in Pakistan, this one is the 12th largest by enrollment, is one of 3 that started in 2025, is one of 10 with no phase, and was the 6th registered.
192 studies on the registry are indexed under Cholelithiasis; 44 are open to participants now.
Browse Cholelithiasis studies →2 of the 12 studies in Cholelithiasis with a site in Pakistan are open now. Recruiting first, the newest first:
Rawal Institute of Health Sciences Islamabad · Sites in Pakistan
Ages 20–70 · Healthy volunteers
King Edward Medical University · Sites in Pakistan
Ages 18–60
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 30 Cholelithiasis studies recruiting now, 20 (67%) set no upper age limit and 7 (23%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.
This study: 14 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2023; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is below the median of 90 across 135 interventional studies indexed under Cholelithiasis.
Median enrollment 80 across the 12 interventional studies. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 12 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Rija Zainab as lead sponsor.
Rija Zainab has 1 study filed under Cholelithiasis — fewer than ten, so there is no comparison to draw.
1 of the studies in Cholelithiasis with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07823803Rawal Institute of Health Sciences IslamabadImprovised Endobag vs Direct Gallbladder Extraction in Laparoscopic Cholecystectomy | 2026-11-30 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Cholelithiasis with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to compare the mean operative time and outcomes of early versus delayed laparoscopic cholecystectomy after ERCP in patients with cholelithiasis and choledocholithiasis. Patients will be randomized into two groups: early cholecystectomy (within 72 hours of ERCP) and delayed cholecystectomy (≥1 month after ERCP). Outcomes include operative time, intra-operative blood loss, hospital stay, and conversion to open cholecystectomy
Gallstones are among the most common surgical problems worldwide, and up to 20% of patients with gallstones also present with stones in the common bile duct. Standard care involves clearance of bile duct stones, typically by Endoscopic Retrograde Cholangiopancreaticography (ERCP), followed by removal of the gallbladder by laparoscopic cholecystectomy (LC).
The timing of cholecystectomy after ERCP remains debated. Early LC (within 72 hours) has been associated with fewer recurrent biliary events, reduced hospital stay, and potentially easier operative conditions. However, delayed LC (after one month) continues to be widely practiced due to institutional factors and scheduling constraints.
This randomized controlled trial at Sheikh Zayed Hospital, Lahore, is designed to evaluate whether early LC after ERCP offers measurable advantages compared with delayed LC. Patients with confirmed cholelithiasis and choledocholithiasis will be randomized into two groups: early surgery and delayed surgery. The trial will provide local evidence to guide surgical practice, focusing on operative efficiency and patient recovery.
By clarifying the optimal timing of LC after ERCP in our patient population, the study aims to support evidence-based surgical decision-making, improve outcomes, and potentially reduce healthcare costs.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will undergo laparoscopic cholecystectomy within 72hours followed by successful ERCP
Procedure: Early laparoscopic cholecystectomy
Patients will undergo laparoscopic cholecystectomy 4 weeks or more after successful ERCP
Procedure: Delayed Laparoscopic cholecystectomy
Laparoscopic removal of gall bladder within 72hours of laparoscopic cholecystectomy
Laparoscopic removal of gall bladder 4 weeks or more after successful ERCP
Mean Operative time
Duration of surgery measured from the first incision to closure of the last incision.
Time frame: During surgery
Length of Hospital Stay
Total number of days from hospital admission to discharge.
Time frame: From admission to discharge (up to 30 days)
Intraoperative Blood Loss
Blood loss measured in milliliters from suction apparatus during surgery.
Time frame: During Surgery
Conversion to Open Cholecystectomy
Number of patients requiring conversion from laparoscopic to open surgery
Time frame: During Surgery
Plan to share: No — Individual participant data (IPD) will not be shared because there is no plan to make individual participant-level data available to other researchers. Only aggregate study results will be reported.
No publications or documents are linked to this record.
Ran from May 2025 to primary completion in Oct 2025, 5 months.
Of 54 non-industry interventional studies with no phase under Cholelithiasis, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 27. This study's 5 months is below that.
Counting every sponsor, half of 58 studies reached it within 15 months; a quarter within 6 and three quarters within 24.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: primary completion Oct 2026 → Oct 2025 and completion Oct 2026 → Feb 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.